Naim M. Maalouf

8.1k total citations · 1 hit paper
134 papers, 5.8k citations indexed

About

Naim M. Maalouf is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Orthopedics and Sports Medicine. According to data from OpenAlex, Naim M. Maalouf has authored 134 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pulmonary and Respiratory Medicine, 53 papers in Nephrology and 25 papers in Orthopedics and Sports Medicine. Recurrent topics in Naim M. Maalouf's work include Kidney Stones and Urolithiasis Treatments (65 papers), Parathyroid Disorders and Treatments (21 papers) and Therapeutic Uses of Natural Elements (20 papers). Naim M. Maalouf is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (65 papers), Parathyroid Disorders and Treatments (21 papers) and Therapeutic Uses of Natural Elements (20 papers). Naim M. Maalouf collaborates with scholars based in United States, Australia and Lebanon. Naim M. Maalouf's co-authors include Khashayar Sakhaee, Orson W. Moe, Charles Y.C. Pak, Beverley Adams‐Huet, Clarita V. Odvina, Joseph E. Zerwekh, Frank Gottschalk, D. Sudhaker Rao, Mary Ann Cameron and Damaris Vega and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Naim M. Maalouf

120 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy

2005 1.1k citations Clarita V. Odvina, Joseph E. Zerwekh et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naim M. Maalouf United States	36	2.2k	1.6k	1.6k	1.2k	1.1k	134	5.8k
Khashayar Sakhaee United States	51	5.0k 2.3×	1.1k 0.7×	3.2k 2.0×	594 0.5×	2.3k 2.2×	175	8.8k
Craig B. Langman United States	45	1.5k 0.7×	1.5k 0.9×	1.5k 0.9×	882 0.7×	1.1k 1.0×	215	7.2k
David A. Bushinsky United States	58	4.5k 2.0×	1.1k 0.7×	5.7k 3.6×	580 0.5×	849 0.8×	239	11.3k
Markus Ketteler Germany	61	2.1k 1.0×	938 0.6×	8.5k 5.3×	882 0.7×	845 0.8×	242	13.3k
Vincent Brandenburg Germany	48	976 0.4×	694 0.4×	3.8k 2.4×	550 0.5×	350 0.3×	151	6.4k
Sharon M. Moe United States	59	2.3k 1.0×	1.8k 1.1×	10.4k 6.5×	1.4k 1.1×	1.2k 1.1×	287	14.4k
Isidro B. Salusky United States	52	1.6k 0.7×	954 0.6×	7.8k 4.9×	984 0.8×	1.9k 1.8×	250	10.9k
Jack W. Coburn United States	56	1.3k 0.6×	543 0.3×	4.9k 3.1×	698 0.6×	1.1k 1.1×	153	9.0k
Armando Torres Spain	43	1.4k 0.6×	415 0.3×	2.6k 1.6×	504 0.4×	622 0.6×	190	6.1k
Gregory D. Gamble New Zealand	35	428 0.2×	1.5k 0.9×	951 0.6×	657 0.5×	531 0.5×	92	4.4k

Countries citing papers authored by Naim M. Maalouf

Since Specialization

Citations

This map shows the geographic impact of Naim M. Maalouf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naim M. Maalouf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naim M. Maalouf more than expected).

Fields of papers citing papers by Naim M. Maalouf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naim M. Maalouf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naim M. Maalouf. The network helps show where Naim M. Maalouf may publish in the future.

Co-authorship network of co-authors of Naim M. Maalouf

This figure shows the co-authorship network connecting the top 25 collaborators of Naim M. Maalouf. A scholar is included among the top collaborators of Naim M. Maalouf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naim M. Maalouf. Naim M. Maalouf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tasian, Gregory E., Jonathan D. Harper, Hussein R. Al‐Khalidi, et al.. (2025). Development of Prediction Models for Severe Pain and Urinary Symptoms After Ureteroscopy With Ureteral Stent Placement: Results From the STENTS Study and Initial Validation of Pain Interference. The Journal of Urology. 213(4). 475–484. 2 indexed citations

Tasian, Gregory E., Naim M. Maalouf, Jonathan D. Harper, et al.. (2025). Validation of an Automated CT Image Analysis in the Prevention of Urinary Stones with Hydration Trial. Journal of Endourology. 39(9). 953–959. 1 indexed citations

Schaub, Jennifer A., Mary Oerline, Joseph J. Crivelli, et al.. (2025). The Effect of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists on 24-Hour Urine Parameters. Kidney360. 6(5). 835–847.

Maalouf, Naim M., et al.. (2024). Use of Cinacalcet for the Management of Primary Hyperparathyroidism in Pregnancy. JCEM Case Reports. 2(7). luae117–luae117. 2 indexed citations

Li, Xilong, et al.. (2024). Fat Distribution and Urolithiasis Risk Parameters in Uric Acid Stone Formers and Patients with Type 2 Diabetes Mellitus. Clinical Journal of the American Society of Nephrology. 20(1). 116–123.

Lehmann, Christoph U., et al.. (2024). Patient Characteristics, Management, and Outcomes in a Novel Cohort of Primary Hyperparathyroidism. Journal of the Endocrine Society. 8(8). bvae096–bvae096. 2 indexed citations

Li, Xilong, et al.. (2024). Changes in 24-Hour Urine Chemistry in Patients with Nephrolithiasis during Weight Loss with Glucagon-Like Peptide 1–Based Therapies. SHILAP Revista de lepidopterología. 5(11). 1706–1712.

Corneli, Amy, Carrie Dombeck, Kevin McKenna, et al.. (2023). The Patient Voice: Stent Experiences After Ureteroscopy—Insights from In-Depth Interviews with Participants in the USDRN STENTS Nested Qualitative Cohort Study. Journal of Endourology. 37(6). 642–653. 3 indexed citations

Li, Xilong, et al.. (2023). Bone health outcomes in post-lung transplant patients with cystic fibrosis. Journal of Cystic Fibrosis. 22(3). 381–387. 2 indexed citations

10.

Li, Xilong, et al.. (2023). Urine pH and Citrate as Predictors of Calcium Phosphate Stone Formation. Kidney360. 4(8). 1123–1129. 6 indexed citations

11.

Dai, Jessica, Naim M. Maalouf, Kathy Hill, et al.. (2022). Alkali Citrate Content of Common Over-the-Counter and Medical Food Supplements. Journal of Endourology. 37(1). 112–118. 7 indexed citations

12.

Maalouf, Naim M., et al.. (2022). Romosozumab-aqqg in the Treatment of Osteoporosis in a Patient With Hypophosphatasia. Journal of the Endocrine Society. 6(12). bvac159–bvac159. 2 indexed citations

13.

Lee, MinJae, Jessica S. Hook, Jessica G. Moreland, et al.. (2022). Evaluation of an association between RANKL and OPG with bone disease in people with cystic fibrosis. Journal of Cystic Fibrosis. 22(1). 140–145. 7 indexed citations

14.

Crivelli, Joseph J., David T. Redden, Robert D. Johnson, et al.. (2022). Associations of Obesity and Neighborhood Factors With Urinary Stone Parameters. American Journal of Preventive Medicine. 63(1). S93–S102. 7 indexed citations

15.

Maalouf, Naim M., Avneesh Chhabra, R. G. Querry, et al.. (2021). Androgen Deprivation Therapy Differentially Impacts Bone and Muscle in the Short Term in Physically Active Men With Prostate Cancer. JBMR Plus. 6(1). e10573–e10573. 5 indexed citations

16.

Bedimo, Roger, Henning Drechsler, Mamta K. Jain, et al.. (2014). The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health. PLoS ONE. 9(8). e106221–e106221. 54 indexed citations

17.

Maalouf, Naim M., et al.. (2010). Hypocitraturia and hyperoxaluria after Roux-en y gastric bypass surgery. Journal of Endourology. 24(8). 1214–1215.

18.

Maalouf, Ghassan, Naim M. Maalouf, Norman G. Schaaf, et al.. (2006). The spinal curvature irregularity index independently identifies vertebral fractures. Osteoporosis International. 18(3). 279–283. 1 indexed citations

19.

Odvina, Clarita V., Joseph E. Zerwekh, D. Sudhaker Rao, et al.. (2005). Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy. The Journal of Clinical Endocrinology & Metabolism. 90(3). 1294–1301. 1074 indexed citations breakdown →

20.

Maalouf, Naim M., Khashayar Sakhaee, Joan H. Parks, et al.. (2004). Association of urinary pH with body weight in nephrolithiasis. Kidney International. 65(4). 1422–1425. 297 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact